A growing cohort in the cancer research community are bringing an unprecedented focus on inequity in cancer care.  Warren Whyte, PhD, Vice President of Scientific Partnerships at ConcertAI, shared in HIT Consultant how a race and ethnicity-based oncology registry like ConcertAI’s ERACE can bring more positive outcomes to populations with health disparities.

“The registry is intended to generate insight into what is driving these inequalities, bring to bear positive outcomes for populations where disparities exist, and support the next generation of researchers in their search for innovative solutions. We also believe that it will expand access for minority populations to cutting-edge cancer care. ”